Penumbra, Inc Increase (Decrease) in Inventories
Penumbra, Inc (PEN) reported Increase (Decrease) in Inventories of $14.34 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-30
- Penumbra, Inc increase (decrease) in inventories for the quarter ending 2026-06-30 was $5.33M, a 53.17% decline year-over-year.
- Penumbra, Inc increase (decrease) in inventories for the quarter ending 2026-03-31 was $9.02M, a 16.20% decline year-over-year.
- Penumbra, Inc increase (decrease) in inventories for the quarter ending 2025-12-31 was $630.00K, a 96.80% decline year-over-year.
- Penumbra, Inc increase (decrease) in inventories for the quarter ending 2025-09-30 was $3.72M, a 83.86% decline year-over-year.
- Penumbra, Inc increase (decrease) in inventories for fiscal 2025 was $26.48M, a 59.67% decline from fiscal 2024.
- Penumbra, Inc increase (decrease) in inventories for fiscal 2024 was $65.66M, a 3.03% decline from fiscal 2023.
- Penumbra, Inc increase (decrease) in inventories for fiscal 2023 was $67.71M, a 9.27% decline from fiscal 2022.
- Penumbra, Inc increase (decrease) in inventories for fiscal 2022 was $74.63M, a 44.76% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $14.34M 10-Q · filed 2026-07-30 | $14.97M derived: sum of 3 quarters · filed 2026-07-30 | $18.69M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $9.02M 10-Q · filed 2026-05-06 | $9.65M derived: sum of 2 quarters · filed 2026-05-06 | $13.37M derived: sum of 3 quarters · filed 2026-05-06 | $24.74M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $630.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.35M derived: sum of 2 quarters · filed 2026-02-25 | $15.72M derived: sum of 3 quarters · filed 2026-07-30 | $26.48M 10-K · filed 2026-02-25 |
| 2025-09-30 | $3.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $15.09M derived: sum of 2 quarters · filed 2026-07-30 | $25.85M 10-Q · filed 2025-11-05 | $45.52M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $11.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $22.13M 10-Q · filed 2026-07-30 | $41.80M derived: sum of 3 quarters · filed 2026-07-30 | $64.84M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $10.76M 10-Q · filed 2026-05-06 | $30.43M derived: sum of 2 quarters · filed 2026-05-06 | $53.47M derived: sum of 3 quarters · filed 2026-05-06 | $64.80M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $19.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $42.70M derived: sum of 2 quarters · filed 2026-02-25 | $54.04M derived: sum of 3 quarters · filed 2026-02-25 | $65.66M 10-K · filed 2026-02-25 |
| 2024-09-30 | $23.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $34.37M derived: sum of 2 quarters · filed 2025-11-05 | $45.99M 10-Q · filed 2025-11-05 | $67.24M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $11.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $22.95M 10-Q · filed 2025-07-29 | $44.20M derived: sum of 3 quarters · filed 2026-02-25 | $64.91M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $11.62M 10-Q · filed 2025-04-23 | $32.86M derived: sum of 2 quarters · filed 2026-02-25 | $53.57M derived: sum of 3 quarters · filed 2026-02-25 | $68.69M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $21.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $41.95M derived: sum of 2 quarters · filed 2026-02-25 | $57.07M derived: sum of 3 quarters · filed 2026-02-25 | $67.71M 10-K · filed 2026-02-25 |
| 2023-09-30 | $20.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $35.83M derived: sum of 2 quarters · filed 2024-10-30 | $46.47M 10-Q · filed 2024-10-30 | $58.78M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $15.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $25.76M 10-Q · filed 2024-07-30 | $38.07M derived: sum of 3 quarters · filed 2025-02-18 | $64.34M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $10.64M 10-Q · filed 2024-05-07 | $22.95M derived: sum of 2 quarters · filed 2025-02-18 | $49.22M derived: sum of 3 quarters · filed 2025-02-18 | $73.51M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $12.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $38.58M derived: sum of 2 quarters · filed 2025-02-18 | $62.87M derived: sum of 3 quarters · filed 2025-02-18 | $74.63M 10-K · filed 2025-02-18 |
| 2022-09-30 | $26.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $50.55M derived: sum of 2 quarters · filed 2023-11-02 | $62.32M 10-Q · filed 2023-11-02 | $68.06M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $24.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $36.05M 10-Q · filed 2023-08-01 | $41.79M derived: sum of 3 quarters · filed 2024-02-22 | $46.06M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $11.76M 10-Q · filed 2023-05-02 | $17.51M derived: sum of 2 quarters · filed 2024-02-22 | $21.77M derived: sum of 3 quarters · filed 2024-02-22 | $31.71M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $5.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $10.01M derived: sum of 2 quarters · filed 2024-02-22 | $19.95M derived: sum of 3 quarters · filed 2024-02-22 | $51.55M 10-K · filed 2024-02-22 |
| 2021-09-30 | $4.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $14.20M derived: sum of 2 quarters · filed 2022-11-03 | $45.81M 10-Q · filed 2022-11-03 | $62.85M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $9.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $41.54M 10-Q · filed 2022-08-05 | $58.58M derived: sum of 3 quarters · filed 2023-02-23 | $66.59M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $31.61M 10-Q · filed 2022-05-03 | $48.65M derived: sum of 2 quarters · filed 2023-02-23 | $56.65M derived: sum of 3 quarters · filed 2023-02-23 | $73.50M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $17.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $25.05M derived: sum of 2 quarters · filed 2023-02-23 | $41.89M derived: sum of 3 quarters · filed 2023-02-23 | $56.98M 10-K · filed 2023-02-23 |
| 2020-09-30 | $8.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $24.85M derived: sum of 2 quarters · filed 2021-11-03 | $39.94M 10-Q · filed 2021-11-03 | $53.49M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $16.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $31.93M 10-Q · filed 2021-08-09 | $45.48M derived: sum of 3 quarters · filed 2022-02-22 | $54.82M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $15.09M 10-Q · filed 2021-05-04 | $28.64M derived: sum of 2 quarters · filed 2022-02-22 | $37.98M derived: sum of 3 quarters · filed 2022-02-22 | $49.77M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $13.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $22.89M derived: sum of 2 quarters · filed 2022-02-22 | $34.68M derived: sum of 3 quarters · filed 2022-02-22 | $41.41M 10-K · filed 2022-02-22 |
| 2019-09-30 | $9.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $21.13M derived: sum of 2 quarters · filed 2020-11-02 | $27.86M 10-Q · filed 2020-11-02 | $34.75M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $11.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $18.52M 10-Q · filed 2020-08-03 | $25.41M derived: sum of 3 quarters · filed 2021-02-23 | $36.86M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $6.73M 10-Q · filed 2020-05-07 | $13.62M derived: sum of 2 quarters · filed 2021-02-23 | $25.07M derived: sum of 3 quarters · filed 2021-02-23 | $29.22M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $6.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $18.34M derived: sum of 2 quarters · filed 2021-02-23 | $22.50M derived: sum of 3 quarters · filed 2021-02-23 | $22.29M 10-K · filed 2021-02-23 |
| 2018-09-30 | $11.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $15.60M derived: sum of 2 quarters · filed 2019-11-07 | $15.39M 10-Q · filed 2019-11-07 | $19.50M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $4.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $3.95M 10-Q · filed 2019-08-06 | $8.06M derived: sum of 3 quarters · filed 2020-02-26 | $15.95M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | -$208.00K 10-Q · filed 2019-05-07 | $3.90M derived: sum of 2 quarters · filed 2020-02-26 | $11.79M derived: sum of 3 quarters · filed 2020-02-26 | $12.56M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $4.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $12.00M derived: sum of 2 quarters · filed 2020-02-26 | $12.77M derived: sum of 3 quarters · filed 2020-02-26 | $18.83M 10-K · filed 2020-02-26 |
| 2017-09-30 | $7.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $8.66M derived: sum of 2 quarters · filed 2018-11-05 | $14.72M 10-Q · filed 2018-11-05 | $20.43M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $770.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $6.83M 10-Q · filed 2018-08-07 | $12.55M derived: sum of 3 quarters · filed 2019-02-26 | $14.53M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $6.06M 10-Q · filed 2018-05-08 | $11.78M derived: sum of 2 quarters · filed 2019-02-26 | $13.76M derived: sum of 3 quarters · filed 2019-02-26 | $16.71M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $5.72M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $7.70M derived: sum of 2 quarters · filed 2019-02-26 | $10.65M derived: sum of 3 quarters · filed 2019-02-26 | $19.74M 10-K · filed 2019-02-26 |
| 2016-09-30 | $1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $4.93M derived: sum of 2 quarters · filed 2017-11-07 | $14.02M 10-Q · filed 2017-11-07 | $21.13M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $2.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $12.04M 10-Q · filed 2017-08-08 | $19.15M derived: sum of 3 quarters · filed 2018-02-27 | $25.84M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $9.08M 10-Q · filed 2017-05-09 | $16.20M derived: sum of 2 quarters · filed 2018-02-27 | $22.89M derived: sum of 3 quarters · filed 2018-02-27 | $27.15M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $7.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $13.80M derived: sum of 2 quarters · filed 2018-02-27 | $18.07M derived: sum of 3 quarters · filed 2018-02-27 | $25.13M 10-K · filed 2018-02-27 |
| 2015-09-30 | $6.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $10.96M derived: sum of 2 quarters · filed 2016-11-03 | $18.01M 10-Q · filed 2016-11-03 | $22.30M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $4.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $11.32M 10-Q · filed 2016-08-09 | $15.61M derived: sum of 3 quarters · filed 2017-02-28 | |
| 2015-03-31 | $7.06M 10-Q · filed 2016-05-09 | $11.34M derived: sum of 2 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $4.29M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $9.44M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $5.16M 10-Q · filed 2015-11-12 | |||
| 2013-12-31 | $3.78M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |